Company / Cash per Share
KalVista Pharmaceuticals, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.10
FY2025
5-year range
$0.64 / $3.10
FY2021-FY2025
Trend
+383.5%
vs FY2024
Sector context
#69 of 205
Health Care
What the data says
Cash per Share changed +383% YoY in FY2025, a notable deviation from the 9-year average annual change of +110%.
Based on SEC 10-K filings.
3.10 in FY2025 with a 5-year CAGR of +27.6%.
Improved from $1.53 to $3.10 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- +27.6%
- 10-Year CAGR
- -
Sector benchmark
#69 of 205 in Health CareTop 34% of 205This company $3.10 Sector average $67.98
▼
-95.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 383.5% year-over-year.
- Ranks #69 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.10 | +383.5% |
| FY2024 | $0.64 | -58.1% |
| FY2023 | $1.53 | +21.5% |
| FY2022 | $1.26 | -55.6% |
| FY2021 | $2.83 | +210.2% |
| FY2020 | $0.91 | -54.7% |
| FY2019 | $2.02 | +674.9% |
| FY2018 | $0.26 | -91.3% |
| FY2017 | $3.00 | -36.0% |
| FY2016 | $4.68 | -51.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026